Impaired antiviral activity of interferon alpha against hepatitis C virus 2a in Huh-7 cells with a defective Jak-Stat pathway

Virology Journal

Volumn 7, Issue , 2010, Pages

  Hazari, Sidhartha ^a   Chandra, Partha K ^a   Poat, Bret ^a   Datta, Sibnarayan ^a   Garry, Robert F ^a   Foster, Timothy P ^b   Kousoulas, Gus ^b   Wakita, Takaji ^c   Dash, Srikanta ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GREEN FLUORESCENT PROTEIN; JANUS KINASE; LUCIFERASE; NONSTRUCTURAL PROTEIN 5A; STAT PROTEIN; HYBRID PROTEIN; NS 5 PROTEIN, HEPATITIS C VIRUS; NS-5 PROTEIN, HEPATITIS C VIRUS; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CLONE; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; GENOME; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HOST CELL; HUMAN; HUMAN CELL; PROMOTER REGION; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS REPLICATION; CELL LINE; CLASSIFICATION; GENETICS; IMMUNOLOGY; LIVER CELL; METABOLISM; METHODOLOGY; REPORTER GENE; STAINING; VIROLOGY;

HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 1;

CELL LINE; GENES, REPORTER; GENOTYPE; GREEN FLUORESCENT PROTEINS; HEPACIVIRUS; HEPATOCYTES; HUMANS; INTERFERON-ALPHA; JANUS KINASES; RECOMBINANT FUSION PROTEINS; STAINING AND LABELING; STAT TRANSCRIPTION FACTORS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 77749314519     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-36     Document Type: Article

References (32)

1. Global challenges in liver disease. R William, Hepatology 2006 44 521 526 10.1002/hep.21347 16941687
2. Viral Hepatitis C. T Poynard MF Yuen V Ratziu CL Lai, Lancet 2003 362 2095 2100 10.1016/S0140-6736(03)15109-4 14697814
3. Diagnosis, management, and Treatment of hepatitis C: An update. MG Ghanay DB Strader DL Thomas LB Seeff, Hepatology 2009 49 1335 1374 10.1002/hep.22759 19330875
4. Development of novel treatment for hepatitis C. DP Webster P Klenerman J Collier KJM Jefffery, Lancet Infect Dis 2009 9 108 117 10.1016/S1473-3099(09) 70020-9 19179226
5. The way forward in HCV treatment finding the right path. MP Manns GR Foster JK Rockstroh S Zeuzem F Zoulim M Houghton, Nature Rev Drug Disco 2007 6 991 1000 10.1038/nrd2411 (Pubitemid 350201789)
6. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. QL Choo G Kuo AJ Weiner LR Overby DW Bradley M Houghton, Science 1989 244 359 362 10.1126/science.2523562 2523562
7. Replication of hepatitis C virus. D Moradpour F Penin CM Rice, Nature Review 2007 5 453 463 10.1038/nrmicro1645 (Pubitemid 46780082)
8. Genetic diversity and evolution of hepatitis C virus-15 years on. P Simmonds, J Gen Virol 2004 85 3173 88 10.1099/vir.0.80401-0 15483230
9. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. J Bukh RH Miller RH Purcell, Semin Liver Dis 1995 15 41 63 10.1055/s-2007-1007262 7597443
10. Genetic analysis of hepatitis C virus in American patients. K Mahoney V Tedeschi G Maertens AM Di Bisceglie J Vergalla JH Hoofnagle R Sallie, Hepatology 1994 20 1405 1411 10.1002/hep.1840200605 7982639
11. Evolutionary analysis of variants of hepatitis C virus found in South-East Asia: comparison with classifications based upon sequence similarity. P Simmonds J Mellor T Sakuldamrongpanich C Nuchaprayoon S Tanprasert EC Holmes DB Smith, J Gen Virol 1996 77 3013 3024 10.1099/0022-1317-77-12-3013 9000092
12. Epidemiology of Hepatitis C (HCV) infection. T Sy MM Jamal, Int J Med Sciences 2006 3 41 46
13. Hepatitis C virus molecular clones: from cDNA to infectious virus particles in cell culture. R Bartenschlager, Curr Opin Microbiol 2006 9 416 422 10.1016/j.mib.2006.06.012 16814596
14. Production of infectious hepatitis C virus from a cloned viral genome. T Wakita T Pietschmann T Kato T Date M Miyamoto Z Zhao K Murthy A Habermann HG Krausslich M Mizokani R Bartenschalager TJ Liang, Nature Medicine 2005 11 791 796 10.1038/nm1268 15951748
15. Complete Replication of hepatitis C virus in cell culture. BD Lindenbach MJ Evans AJ Syder B Wolk TL Tellinghuisen CC Liu T Maruyama RO Hynes DR Burton JA McKeating CM Rice, Science 2005 309 623 626 10.1126/science.1114016 15947137
16. Robust hepatitis C virus infection in vitro. J Zhong P Gastaminza G Cheng S Kapadia T Kato DR Burton SF Wieland SL Uprichard T Wakita FV Chisari, Proc Natl Acad Sci 2005 102 9294 9299 10.1073/pnas.0503596102 15939869
17. New therapies for hepatitis C virus infection. V Soriano MG Peters S Zeuzem, Clinical Infect Dis 2009 48 313 320 10.1086/595848
18. Interferon alpha, beta, gamma each inhibits hepatitis C virus replication at the levels of internal ribosome entry site mediated translation. S Dash R Prabhu S Hazari FO Bastian RF Garry W Zou S Haque V Joshi FG Regenstein SN Thung, Liver International 2005 25 1 15 10.1111/j.1478-3231.2005.01082.x 15698392
19. Interferon alpha-2b inhibits negative-strand RNA and protein expression from full-length HCV1a infectious clone. R Prabhu V Joshi RF Garry FO Bastian S Haque F Regenstein S Thung S Dash, Exp Mol Pathol 2004 76 242 52 10.1016/j.yexmp.2004.01.004 15126107
20. Interferon alpha inhibits internal ribosome entry site mediated translation of green fluorescence protein from six different HCV genotypes. S Hazari A Patel R Prabhu FO Bastian RF Garry V Joshi S Haque FG Regenstein R Elliot S Dash, J Gen Virol 2005 86 3047 3053 10.1099/vir.0.81132-0 16227227
21. Activation of interferon stimulated response element in a Huh-7 cell line replicating hepatitis C virus sub-genomic RNA. M Pai R R. Prabhu A Panebra S Nangle FO Bastian RF Garry K Agrawal S Goodbourn S Dash, Intervirology 2005 48 301 311 10.1159/000085099 15956798
22. Reduced expression of Jak-1 and Tyk-2 proteins leads to interferon resistance in hepatitis C virus replicon. S Hazari L Taylor S Haque RF Garry S Florman R Luftig F Regenstein S Dash, Virol J 2007 4 89 102 10.1186/1743-422X-4- 89 17877826
23. Efficient replication of the genotype 2a hepatitis C virus sub-genomic replicon. T Kato T Date M Miyamoto A Furusaka K Tokushige M Mizokami T Wakita, Gastroenterology 2003 125 1808 1817 10.1053/j.gastro.2003.09.023 14724833
24. Simultaneous detection of HCV and HIV-1 by SYBR Green real time multiplex RT-PCR technique in plasma samples. D Gibellini F Gardini F Vitone P Schiavone G Furlini M Carla Re, Mol Cell Probes 2006 20 223 229 10.1016/j.mcp.2005.12.005 16537101
25. Insertion of green fluorescence protein into non-structural protein 5A allows direct visualization of functional hepatitis C virus replication complexes. D Moradpour MJ Evans R Gosert Z Yuan HE Blum SP Goff BD Lindenbach CM Rice, J Virol 2004 78 7400 7409 10.1128/JVI.78.14.7400-7409.2004 15220413
26. Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. G Koutsoudakis A Kaul E Steinmann S Kallis V Lohmann T Pietschmann R Bartenschalager, J Virol 2006 80 5308 5320 10.1128/JVI.02460-05 16699011
27. Monitoring the antiviral effect of alpha interferon on individual cells. CS Kim J-H Jung T Wakita S-K Yoon S-K Jang, J Virol 2007 81 8814 8820 10.1128/JVI.02824-06 17537862
28. Analysis of hepatitis C virus super infection exclusion by using novel fluorochrome gene-tagged viral genome. T Schaller N Appel G Koutsoudakis S Kallis V Lohmann T Pietschmann R Bartenschlager, J Virol 2007 81 4591 4603 10.1128/JVI.02144-06 17301154
29. Comparison between sub-genomic replicons of hepatitis C virus genotypes 2a (JFH-1) and 1b (Con1 NK5.1). M Miyamoto T Kato T Date M Mizokami T Wakita, Intervirology 2006 49 37 43 10.1159/000087261 16166787
30. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. AU Neumann NOH Lam Dahari DR Gretch TE Wiley, Science 1998 282 103 107 10.1126/science.282.5386.103 9756471
31. Interferon resistance of hepatitis C virus replicon-harbouring cells is caused by functional disruption of type 1 interferon receptors. K Naka K Takemoto K Abe H Dansako M Ikeda K Shimotohno N Kato, J Gen Virol 2005 86 2787 2792 10.1099/vir.0.81124-0 16186233
32. Variants in Interferon-alpha pathway genes and response to pegylated interferon-alpha 2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C Antiviral Long-term treatment against Cirrhosis trial. TM Welzel TR Morgan HL Bonkovsky D Naishadham RM Pfeiffer EC Wright AA Hutchinson AT Crenshaw A Bashirova M Corrington, Hepatology 2009 49 1847 1858 10.1002/hep.22877 19434718